Estados Unidos · Revistas de economía · Markets Insider (Business Insider)

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

Publicado por Markets Insider (Business Insider) · Estados Unidos hace 3 h

NANJING, China, Oct. 25, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (âLeads Biolabsâ, Stock Code: 9887.HK) today announced updated firstâinâhuman clinical…

Leer el artículo completo en Markets Insider (Business Insider) Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (markets.businessinsider.com)

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

También te puede interesar

‘Everyone is hedging.’ As the U.S. and China divide the world into rival AI blocs, that lends power to ‘swing countries’ in between

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

Millennials are having their midlife career crisis

Carson Hocevar Is Telling NASCAR Fans To Vote For Somebody Else

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

Compartir

También te puede interesar

‘Everyone is hedging.’ As the U.S. and China divide the world into rival AI blocs, that lends power to ‘swing countries’ in between

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

Millennials are having their midlife career crisis

Carson Hocevar Is Telling NASCAR Fans To Vote For Somebody Else